Marina Sokolsky-Papkov, Ph.D., a research assistant professor at the UNC Eshelman School of Pharmacy, is the recipient of a Hero Fund grant from the St. Baldrick’s Foundation to support her research into more effective methods of treating medullosblastoma, the most common malignant brain tumor seen in children.
Some medulloblastomas are driven by excessive activity of a signaling pathway called SHH, and for patients with these tumors, SHH-pathway inhibitors may offer new hope, Sokolsky said. She is teaming with a physician-scientist Timothy Gershon, M.D., Ph.D., on the project. Gershon is an associate professor of neurology at the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center.
To read the full Eshelman School of Pharmacy article, please click here.
